Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) have been given a consensus recommendation of “Hold” by the ten research firms that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and five have given a buy recommendation to […]
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Rating) had its price target reduced by stock analysts at The Goldman Sachs Group from $8.00 to $7.00 in a research note issued to investors on Tuesday, Stock Target Advisor reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s price target would indicate a […]
Zacks Investment Research Upgrades Rhythm Pharmaceuticals (NASDAQ:RYTM) to Hold etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.